Page last updated: 2024-08-26

cilastatin and Hematologic Malignancies

cilastatin has been researched along with Hematologic Malignancies in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, W; Jing, Y; Li, J; Wang, Q; Yu, L; Yuan, L; Zhao, X; Zhou, D	1
Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L	1
Björkholm, M; Cherif, H; Engervall, P; Hast, R; Johansson, P; Kalin, M; Ljungman, P	1

Trials

2 trial(s) available for cilastatin and Hematologic Malignancies

Article	Year
Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia. Clinical transplantation, 2016, Volume: 30, Issue:3 Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Febrile Neutropenia; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Risk Factors	2016
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome	2004

Article

Year

Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.

Clinical transplantation, 2016, Volume: 30, Issue:3

Topics: Adult; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Febrile Neutropenia; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prognosis; Risk Factors

2016

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.

Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:8

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fever; Follow-Up Studies; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Probability; Prospective Studies; Risk Assessment; Single-Blind Method; Survival Analysis; Sweden; Treatment Outcome

2004

Other Studies

1 other study(ies) available for cilastatin and Hematologic Malignancies

Article	Year
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin	2009

Article

Year

Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:4

Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin

2009